Dear Nick

Many thanks for your reply :)  The reason I am using $DES is because as my next 
step will evaluate adding transit compartments to the model.  I'm currently 
trying to sort the late kinetics before I tackle the early disposition.  I've 
already investigated transit models with this data set having just deleted BQL 
data but the WRES vs time plots show bias at the late time points (FOCE).

I've been trying out your suggestions (and others suggested by Jeroen 
Elassaiss, many thanks Jeroen);

If I fix all ETAs to zero, I then get problems with:

ERROR: NONMEM terminated with the error message:
     SUM OF "SQUARED" WEIGHTED INDIVIDUAL RESIDUALS IS INFINITE

If I allow an ETA on CL only (initial estimate 0.01) I get

0PRED EXIT CODE = 1
0INDIVIDUAL NO.       1   ID= 1.00000000000000E+00   (WITHIN-INDIVIDUAL) DATA 
REC NO.   2
 THETA=
  6.96E+02   5.13E+02   2.60E+02   5.60E+03   2.05E+04   3.80E+04   5.48E-01   
1.01E-01   2.00E-01
 OCCURS DURING SEARCH FOR ETA AT A NONZERO VALUE OF ETA
 ERROR IN LSODI1: CODE  21
 ERROR OCURRED WHILE ATTEMPTING TO OBTAIN INITIAL VALUES FOR ATOL
 Elapsed estimation time in seconds:     0.05

This time point is my first occurrence of BQL (FLG=1), not sure if this is 
relevant.  I don't think the initial estimates of THETA are too far out, as 
above, this data set has been modelling before using FOCE and omitted BQL data 
points.

I'm wondering whether log transforming the data may help, but unsure of the 
implementation with M3.

Many thanks for your input, much appreciated :)

All best wishes

Ann

________________________________
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On 
Behalf Of Nick Holford
Sent: Friday, 29 October, 2010 11:50
To: 'nmusers@globomaxnm.com'
Subject: Re: [NMusers] Hessian of posterior density is non positive definite 
during search
Ann,

This error message usually means try NONMEM thinks your OMEGA initial estimates 
are weird.  A leading suspect would be the OMEGA estimates for the two lag time 
parameters. Try fixing both of them to zero and see if that gets your model 
going. If that doesn't work then you could try fixing all OMEGA values to zero 
then adding them in one at a time.

You don't need to use $DES for your linear model. $SUB ADVAN11 is a closed form 
3 cpt model with bolus/zero order input (or ADVAN12 with first order absorption 
as well).

An efficiency tip -- there is no point calling the time consuming PHI() 
function until you really need it and also no need for a FLG data item. You can 
simplify your $ERROR code like this:

$ERROR
SD=F*THETA(9) ; any residual error model you like assuming $SIGMA 1 FIX
LLOQ = 0.4 ; nm/L
IF (DV.GE.LLOQ) THEN ; non BQL values
      F_FLAG=0
     Y = F + SD*ERR(1))
ELSE ; BQL values
     F_FLAG=1
     Y = PHI((LLOQ-F)/SD)
ENDIF

Best wishes,

Nick

On 29/10/2010 9:50 p.m., Ann Rigby-Jones wrote:

Hello NMUsers

I am trying to reanalyse some data using the M3 method (Ahn et al, Likelihood 
based approaches to handling data below the quantification limit using NONMEM 
VI, J Pharmacokinet Pharmacodyn. 2008).  I had previously used M6 and wanted to 
try something potentially more robust.

I'm having problems with a "Hessian of posterior density is non positive 
definite during search" error occurring as soon as NONMEM is started.  It is 
suggested that this may be caused by including time zero records in the 
analysis (when MDV or EVID = 0) but I've double-checked and I can't find any 
incidence of this.

My control stream is pasted below and I can send an extract of data if that 
helps?

Any ideas very gratefully received!

Many thanks :)

Ann

$PROBLEM PK 3comp LAG BLQ M3
$INPUT ID DOSE AMT RATE DUR TIME DV EVID ART FLG AGE WGT MDV
$DATA step1&2PKBLQ.csv IGNORE=#
$SUBROUTINES ADVAN9 TOL=9
$MODEL
COMP(CENTRAL, DEFOBS)  ;1
COMP(PERIPH1)  ;2
COMP(PERIPH2)  ;3

$PK

CL=THETA(1)*EXP(ETA(1))
Q2=THETA(2)*EXP(ETA(2))
Q3=THETA(3)*EXP(ETA(3))
V1=THETA(4)*EXP(ETA(4))
V2=THETA(5)*EXP(ETA(5))
V3=THETA(6)*EXP(ETA(6))

K10=CL/V1
K12=Q2/V1
K13=Q3/V1
K21=Q2/V2
K31=Q3/V3

S1=V1

IF (DUR.EQ.10) THEN
ALAG1=THETA(7)*EXP(ETA(7))
ELSE
ALAG1=THETA(8)*EXP(ETA(7))
ENDIF

$DES
DADT(1)=A(2)*K21 + A(3)*K31 - A(1)*(K10+K12+K13)
DADT(2)=A(1)*K12 - A(2)*K21
DADT(3)=A(1)*K13 - A(3)*K31

$ERROR

SIG1=THETA(9)
LOQ = 0.4 ; nm/L
IPRED = F
DUM = (LOQ-IPRED)/(SIG1*IPRED)
CUMD=PHI(DUM)
IF(FLG.EQ.0)THEN ; FLG=0, MDV=0 non BQL values
F_FLAG=0
Y = F*(1+SIG1*ERR(1))
ENDIF
IF(FLG.EQ.1)THEN ; FLG=1, MDV=0 BQL values
F_FLAG=1
Y=CUMD
ENDIF

$THETA (0, 696)   ;CL
$THETA (0, 213)   ;Q2
$THETA (0, 2600)    ;Q3
$THETA (0, 5600)   ;V1
$THETA (0, 50500)   ;V2
$THETA (0, 38000)   ;V3
$THETA (0.2167, 0.548,1) ;ALAG 10MIN
$THETA (0.00833, 0.101, 1) ;ALAG 1MIN
$THETA (0, 0.2)   ;SIG1

$OMEGA (0.0121) ; ETA CL
$OMEGA (0.455) ; ETA Q2
$OMEGA (0.118) ; ETA Q3
$OMEGA (0.0919) ; ETA V1
$OMEGA (0.324) ; ETA V2
$OMEGA (0.0664) ; ETA V3
$OMEGA (1.02)  ; ETA LAG SHARED

$SIGMA (0.0622)

$ESTIMATION METHOD=1 LAPLACIAN NUMERICAL SLOW PRINT=1 MAX=9999 NOABORT SIG=3

$COVA
$TABLE ID EVID AMT TIME IPRED
       NOPRINT FILE=AllRecords.txt
$TABLE ID CL Q2 Q3 V1 V2 V3
       ETA1 ETA2 ETA3 ETA4 ETA5 ETA6 ETA7
       FIRSTONLY  NOPRINT  NOAPPEND FILE=FirstRecords.txt
_______________________________________________________________________
Ann Rigby-Jones PhD MRSC
Research Fellow in Pharmacokinetics & Pharmacodynamics
Peninsula College of Medicine & Dentistry, UK
_______________________________________________________________________



--

Nick Holford, Professor Clinical Pharmacology

Dept Pharmacology & Clinical Pharmacology

University of Auckland,85 Park Rd,Private Bag 92019,Auckland,New Zealand

tel:+64(9)923-6730 fax:+64(9)373-7090 mobile:+64(21)46 23 53

email: n.holf...@auckland.ac.nz<mailto:n.holf...@auckland.ac.nz>

http://www.fmhs.auckland.ac.nz/sms/pharmacology/holford

________________________________
This message and any attachments are solely for the intended recipient. If you 
are not the intended recipient, disclosure, copying, use or distribution of the 
information included in this message is prohibited --- Please immediately and 
permanently delete.
________________________________

Reply via email to